Heterozygous missense mutations in lysyl oxidase (LOX) are associated with thoracic aortic aneurysms and dissections. To assess how LOX mutations modify protein function and lead to aortic disease, we studied the factors that influence the onset and progression of vascular aneurysms in mice bearing a Lox mutation (p.M292R) linked to aortic dilation in humans. We show that mice heterozygous for the M292R mutation did not develop aneurysmal disease unless challenged with increased hemodynamic stress. Vessel dilation was confined to the ascending aorta although both the ascending and descending aortae showed changes in vessel wall structure, smooth muscle cell number and inflammatory cell recruitment that differed between wild-type and mutant animals. Studies with isolated cells found that M292R-mutant LOX is retained in the endoplasmic reticulum and ultimately cleared through an autophagy/proteasome pathway. Because the mutant protein does not transit to the Golgi where copper incorporation occurs, the protein is never catalytically active. These studies show that the M292R mutation results in LOX loss-of-function due to a secretion defect that predisposes the ascending aorta in mice (and by extension humans with similar mutations) to arterial dilation when exposed to risk factors that impart stress to the arterial wall.
ABSTRACT
Heterozygous missense mutations in lysyl oxidase (LOX) are associated with thoracic aortic aneurysms and dissections. To assess how LOX mutations modify protein function and lead to aortic disease, we studied the factors that influence the onset and progression of vascular aneurysms in mice bearing a Lox mutation (p.M292R) linked to aortic dilation in humans. We show that mice heterozygous for the M292R mutation did not develop aneurysmal disease unless challenged with increased hemodynamic stress. Vessel dilation was confined to the ascending aorta although both the ascending and descending aortae showed changes in vessel wall structure, smooth muscle cell number and inflammatory cell recruitment that differed between wild-type and mutant animals. Studies with isolated cells found that M292R-mutant LOX is retained in the endoplasmic reticulum and ultimately cleared through an autophagy/proteasome pathway. Because the mutant protein does not transit to the Golgi where copper incorporation occurs, the protein is never catalytically active. These studies show that the M292R mutation results in LOX loss-of-function due to a secretion defect that predisposes the ascending aorta in mice (and by extension humans with similar mutations) to arterial dilation when exposed to risk factors that impart stress to the arterial wall.
INTRODUCTION
Thoracic aortic aneurysm and dissection (TAAD) is a major cardiovascular health problem that arises from mutations that alter vascular extracellular matrix (ECM), smooth muscle cell function, or growth factor signaling pathways (1) . In contrast to abdominal aortic aneurysms, TAAD has a strong genetic component with pathogenic variants typically inherited in an autosomal-dominant manner (2) . A single highly penetrant, pathogenic mutant is responsible for disease in only one-fourth of individuals with TAAD, indicating that other undiscovered genetic factors influence disease onset and progression. In addition to the known pathogenic gene mutations, low-penetrant ''risk variants'' interact with other genetic or environmental factors to trigger disease or to increase the risk for developing disease but are not themselves pathogenic (2) . Significant risk factors for TAAD, primarily when occurring in the background of low-penetrant disease-predisposing variants, are hypertension and bicuspid aortic valve (1) .
A common histopathological feature of TAAD in humans is fragmented elastin in the aortic medial region (3) . Elastin is the most abundant ECM protein in the aorta where it plays a central role in the vessel's ability to expand and recoil in response to pulsatile blood flow.
Smooth muscle cells (SMCs) synthesize and organize the protein into fenestrated sheets (lamellae) that separate smooth muscle cell layers. The secreted form of elastin (tropoelastin) undergoes extensive crosslinking outside the cell to form an elastic polymer, which is the functional form of the protein. The enzyme responsible for initiating crosslink formation is lysyl oxidase (LOX), a copper-binding amine oxidase that oxidizes lysine e-amino groups in elastin and fibrillar collagens to aldehydes that then spontaneously react to form covalent linkages between and within proteins (4, 5) . Approximately 90% of the lysine residues in elastin undergo crosslink formation, which makes it one of the most highly crosslinked and most stable proteins in the body (4) . Inactivation of the Lox gene in mice results in early postnatal death due to ruptured aortic aneurysms, emphasizing the critical role of fully crosslinked, functional elastin in maintaining aorta integrity and function (6, 7) . The gene inactivation studies also show that other LOX isoforms cannot substitute for the loss of LOX in large, elastin-rich vessels.
LOX, in vertebrates, belongs to a family of five copper-dependent enzymes (LOX, LOXL1-4) that show a high degree of homology in their carboxy-terminal catalytic domain but differ in their amino-terminal sequences. LOXL2-4 form a subgroup that shares four amino-terminal scavenger receptor cysteine-rich domains that influence substrate binding but appear to have little role in regulating catalytic activity (8, 9) . LOX and LOXL1, in contrast, are synthesized without scavenger receptor sequences but have a propeptide domain that keeps the enzymes in a latent state until proteolytically processed outside the cell by bone morphogenic protein 1 (BMP1)/Tolloid-like metalloproteinases (10, 11) . Substrate specificity for each of the lysyl oxidases is still under investigation, but gene inactivation studies and phylogenetic analysis suggest that LOX and LOXL1 contribute to crosslinking of elastin and fibrillar collagens whereas LOXL2-4 have different substrate specificities (12, 13) . All five LOX isoforms are synthesized in the endoplasmic reticulum and traffic to the Golgi where the inactive apoenzyme binds copper and forms the cofactor lysyl tyrosine quinone (LTQ); both copper and LTQ are essential active site components required for catalytic activity (14) .
Mutations within LOX in families with TAAD were recently identified by whole-exome sequencing (3, 15) . Aortic disease in these families followed autosomal-dominant inheritance, suggesting that one mutant LOX allele is sufficient to influence disease initiation or progression.
Previously, we identified a LOX catalytic site mutation (p.Met298Arg) in a family with a history of TAAD (3) . By introducing this human mutation into the homologous position in the mouse genome using CRISPR/Cas9 genome editing technology (c.857T>G encoding p.M292R, hereafter referred to as Mu), we confirmed that this amino acid change caused ruptured TAAD and perinatal death when both alleles were mutated (Lox Mu/Mu ) (3). In contrast to humans that developed TAAD when heterozygous for this LOX variant, we did not observe aneurysms or other arterial disease in mice with a similar genotype (Lox +/Mu ) unless challenged with hypertension. In this report, we show that the nature of the functional loss associated with the methionine to arginine change in LOX results from a secretion defect where the protein is retained in the endoplasmic reticulum and degraded through an autophagy/proteasome pathway.
We also show that the vessel wall alterations associated with LOX functional haploinsufficiency increase the likelihood of developing vascular disease in association with environmental factors that increase wall stress.
RESULTS

Lox
+/Mu adult animals are predisposed to aortic dilation in response to hypertension.
The generation and characterization of mice expressing the M292R mutation was described in a previous publication (3). Mice heterozygous for this Lox missense variant appear grossly normal, have normal blood pressure, and show no increased mortality through two years of age. Aortic diameter and circumferential wall stiffness at physiological blood pressure in Lox +/Mu animals is normal, but ascending aortic length measured from the aortic root to the brachiocephalic artery is 10% longer than wild-type mice (3).
Hypertension is a known risk factor associated with aortic dilation (16 Figure 1B) . Biaxial pressure-diameter testing showed the ascending aorta in AngIItreated Lox +/Mu animals to be ~25% larger than the aorta from wild-type or saline-treated controls at mean physiological blood pressure ( Figure 1C) . Figure 1D ), nor were dilations or areas of stenosis found in the aortic arch, descending aorta or abdominal aorta.
AngII treatment leads to vessel wall thickening and changes in vascular cellularity
On a structural level, AngII treatment resulted in ascending and descending aortic wall thickening in Lox +/Mu animals, but there were no changes in elastic lamellar number or lamellar organization, quantified by medial area measurement (Figure 2A , and Supplemental Figure   1A ). Figure 1C) . Hydroxyproline levels (as a measure of total collagen) trended higher in vessels from the mutant animals but were not significantly different from wildtype when normalized to the change in total protein (Supplemental Figure 1D ). Higher protein quantities are consistent with the increase in wall thickness that occurred with AngII treatment (Supplemental Figure 1B) . and Agtr2) were detected and there was no difference in their expression levels compared to wild-type controls (Supplemental Figure 2A) . Thus, the potential for AngII receptor-mediated signaling is similar in both genotypes.
Many AngII-induced responses on SMCs are attributable to stimulation of NADPH oxidase with the subsequent generation of reactive oxygen species (ROS) (21, 22) . We used dihydroethidium, a cell-permeable compound that interacts with superoxide, to assess oxidant levels in sections of wild-type and mutant ascending aorta and found no difference between the two genotypes (Supplemental Figure 2B) . Thus, differences in levels of oxidative stress do not appear to be a factor in the AngII susceptibility of Lox +/Mu mice.
In many models of aortic disease, the presence of proteases that degrade elastin can initiate and propagate disease by degrading the elastic fiber system in the vessel wall. We therefore investigated whether three elastolytic matrix metalloproteinases (MMPs) commonly linked to vascular remodeling-MMP2, MMP9, and MMP12-were differentially expressed in mutant versus wild-type aorta. mRNA levels showed no difference in MMP2 and MMP9 expression, and diminished expression of MMP12 in the mutant aorta (Supplemental Figure   2C Figure 4B ). These findings indicate that the mutant protein is poorly secreted and is retained intracellularly as the proenzyme.
Immunofluorescence imaging with an antibody to LOX showed minimal intracellular staining in Lox +/+ cells, confirming that wild-type LOX is secreted efficiently ( Figure 5A ).
Staining of Lox
Mu/Mu cells, however, showed abundant intracellular staining, consistent with the immunoblot results described above. The staining pattern for intracellular LOX was typical of accumulation within the endoplasmic reticulum (ER), which was confirmed by co-localization of LOX with calnexin, an ER-resident protein ( Figure 5B,C).
A direct interaction between LOX and calnexin was shown using co-immunoprecipitation Cell lysates were immunoprecipitated with an anti-calnexin antibody followed by immunoblotting using an antibody to LOX. LOX protein was detected in calnexin immunoprecipitates from all genotypes except Lox -/-, confirming an interaction between the two proteins ( Figure 5D ).
M292R Lox has an altered protein conformation
The It is important to note that pancreatic elastase does not cleave after methionine or arginine, so the Met-to-Arg mutation does not create or negate a protease cleavage site for this enzyme. Together, the conformational difference between wild-type and mutant protein suggests that M292R LOX is misfolded, which is consistent with its protracted interaction with calnexin in the ER.
LOX-M292R does not elicit an ER stress response
Accumulation of misfolded proteins in the ER generally leads to ER stress, which subsequently activates the unfolded protein response (UPR) (23 suggesting that mutant protein does not accumulate to levels that would produce dilated saccules.
Together, these results suggest that LOX protein containing the M292R mutation does not induce significant ER stress. The autophagy activation markers LC3-I and -II were also elevated in mutant compared to wildtype cells ( Figure 8A, C, D) , providing more evidence for increased autophagy.
Increased activation of autophagy in
We also used electron microscopy to screen for the presence of autophagosome-like vesicles in wild-type and mutant cells (Supplemental Figure 4) . We observed that multi-and single-membrane vesicles typical of autophagosomes were particularly abundant in the perinuclear region but were also present throughout the cytoplasm of Lox Mu/Mu cells. Such structures were rare in wild-type cells. Together, the existence of autophagic vesicles along with increased expression of autophagy activation markers in mutant cells is consistent with the clearance of misfolded mutant LOX from the ER through an autophagy/proteasome pathway.
Mutant LOX does not influence the secretion of the wild-type protein
To assess whether the secretion of wild-type LOX is affected by the presence of M292R mutant protein, we transiently expressed plasmids containing wild-type LOX, and M292R LOX In Lox -/-MEFs transfected with 2.5 µg of M292R Lox-mApple plasmid, LOX protein was observed inside the cell by fluorescence microscopy, but no LOX protein was detected in conditioned medium by western blot, consistent with the inability of M292R LOX to be secreted.
To determine if mutant LOX alters the secretion of the wild-type protein, or if the wild-type protein acts as a chaperone to facilitate the secretion of the mutant protein, we co-transfected cells with 1.25 µg each of wild-type and mutant plasmid, which is half as much as was used for single plasmid transfection. If mutant LOX does not affect the secretion of the wild-type protein, then LOX should be detected in conditioned medium, but at half the level of the single plasmid transfection. If the mutant protein has an adverse effect on wild-type LOX secretion, then levels will be lower than 50%. If wild-type LOX acts as a chaperone to facilitate secretion of the mutant protein, then the combination of both secreted proteins would be higher than 50% and possibly equivalent to the wild-type transfection (1.25 + 1.25 = 2.5 µg). Figure 9 shows that LOX protein was detected in conditioned medium of doubly transfected cells at half the level of singly transfected cells, confirming that the mutant protein does not affect the secretion of wildtype LOX.
M292R pro-peptide processing
Our experimental results are consistent with the M292R mutation being a loss-offunction phenotype due to a secretion defect. The final activation step of the pro-enzyme occurs outside the cell through proteolytic separation of the pro-peptide and catalytic domains. To determine if M292R pro-LOX could be processed to the 30 kDa mature form if it were secreted, cell lysates from wild-type and mutant MEFs were incubated with recombinant BMP-1 (rBMP-1), the enzyme responsible for pro-peptide cleavage. Western blot analysis showed that BMP-1 appropriately processed both wild-type and M292R pro-LOX to the 30 kDa mature form (Supplemental Figure 6) . Thus, the mutation does not inhibit pro-peptide processing. The processed mutant protein was not assayed for oxidase activity because intracellular LOX in M292R MEFs does not have bound copper and cannot be enzymatically active.
DISCUSSION
Lysyl oxidase plays a critical role in vascular ECM maturation by catalyzing the crosslinking of elastin and fibrillar collagens, the two major ECM protein classes in the aortic wall. Phylogenic studies suggest that the current form of vertebrate LOX co-evolved with elastin and helped facilitate the appearance of a closed circulatory system (12, 25) . Therefore, it is no surprise that mutations in LOX give rise to vascular insufficiency and disease. All LOX mutations associated with TAAD in humans show autosomal dominant inheritance and most result in lossof-function. We know from mouse studies that inactivation of both Lox alleles is lethal and that other members of the LOX family cannot assume LOX's critical role in vascular development and maintenance of the vessel wall. In this report, we utilize a mouse model of a wellcharacterized human mutation to explore how LOX haploinsufficiency leads to vascular dilation and aneurysm formation. While several AngII-induced vascular changes were expected (19, 27) and common to wild-type and mutant animals, there were also significant differences. For instance, medial expansion was evident in both genotypes, but the effect was most notable in mutant mice where there was an increase in the number of smooth muscle cells between the elastic lamellae. This response is particularly unusual since the intra-lamellar space is typically populated by a single smooth muscle cell layer, as can be seen in vessels from saline-treated Lox +/+ and Lox +/Mu animals ( Figure 2) . The opposite change occurred in wild-type vessels where there were fewer smooth muscle cells in response to AngII, suggesting AngII-related apoptosis or growth suppression (26), which we did not assess.
Another cellular change in the ascending and descending aorta following AngII treatment was the accumulation of macrophages in the aortic wall of both wild-type and Lox +/Mu mice.
CD68+ cells were found in the adventitia of both genotypes, with fewer cells in the medial layer.
In AngII-treated wild-type mice, CD68+ cells accumulated in the intima and inner elastic layers of the media and did not localize to breaks in elastic lamella, as has been reported in other models (18, 20) . Their location within the wall, however, shows that some cells were able to penetrate past the internal elastic lamina into the first or second layer of smooth muscle cells. Our previous studies showed that mice with the Lox M292R mutation share numerous phenotypic traits with Lox +/-animals (3), suggesting that M292R is a loss-of-function mutation in mice and humans. Even though the amino acid change is in the catalytic domain of LOX close to the copper binding site, it was not clear whether the mutation results in a catalytically dead enzyme or if some other aspect of LOX processing is negatively affected by the mutation. Our data show that the answer fits both possibilities: the mutant protein is retained in the ER and not secreted, and the enzyme is catalytically dead because of its inability to traffic to the Golgi where it needs to bind copper and form the redox quinone cofactor LTQ required for catalytic activity (33) . Even though we found that the pro-peptide of mutant pro-LOX could be cleaved by rBMP-1 similar to wild-type LOX, full-length LOX in the ER can never be catalytically active even if pro-peptide processing does occur.
Medial CD68+ cells in
Why mutant LOX is retained in the ER is not clear, but our data point to protein misfolding as a probable cause. ER retention is characteristic of incompletely folded proteins.
Folding intermediates of most secreted proteins interact with the calnexin/calreticulin protein complex in the ER to achieve the proper native conformation required for secretion (34) . The calnexin/calreticulin protein complex recognizes N-linked glycan structures (LOX has three Nlinked glycosylation sites in the pro-peptide region (11) ) that undergo cycles of sugar residue removal and addition. Once folded correctly, calnexin and calreticulin dissociate, and the folded proteins are transported from the ER to the Golgi apparatus. Mutant LOX colocalized intracellularly with calnexin and was isolated bound to calnexin in cellular extracts, suggesting that the protein remains misfolded despite repeated folding interactions with calnexin.
Furthermore, the differential susceptibility to proteolytic degradation of mutant compared to wild-type LOX is consistent with structural differences between the two proteins.
It was interesting that mutant LOX accumulation in the ER did not induce an appreciable unfolded protein response. We saw no up-regulation in mutant cells of the ER stress-related markers Bip (an ER luminal chaperone protein and critical ER stress sensor), Atf4, (a transcription factor downstream of PERK that plays a crucial role in the adaptation to ER stress), or Chop (a transcription factor regulated by ATF4 that drives pro-apoptotic gene transcription).
Nor could we detect in mutant cells an increase in ER volume frequently associated with ER stress. One pathway whereby ER stress is mitigated is by removal from the ER of mutant protein and degradation at the lysosome (ERAD-II) or proteasome (ERAD-I) (24) . We were unable to localize LOX within lysosomes but did find increased expression of the autophagy markers p62 and LC3. Electron microscopy also identified an increased number of autophagic vesicles in and examined in cell lysates, a portion of the pro-LOX protein was processed to its active form and was able to oxidize substrate at rates approximately equivalent to the wild-type enzyme (S348R) or with ~50% lower activity (S280R) (2, 15) . Enzymatic activity in conditioned medium from the transfected cells was not evaluated, so it is not known if these LOX variants are efficiently secreted. However, the fact that the proteins are catalytically active implies trafficking through the Golgi and proteolytic removal of the propeptide domain. Thus, unlike the M292R mutation that is retained in the ER, the S348R and S280R variants appear capable of traversing the secretory pathway. How these proteins, that have full (or somewhat reduced) catalytic activity, cause thoracic aortic disease is an interesting question. An intriguing possibility is that the mutant proteins contribute to disease pathogenesis through mechanisms that do not involve their amine oxidase activity. Noncatalytic functions for lysyl oxidase are emerging (5, 36, 37) and much remains to be learned about how mutations in this interesting multifunctional enzyme lead to aortic disease.
MATERIALS AND METHODS
Antibodies
Antibodies used in this study are described in supplemental table 1.
Mouse models and cell isolation
A knock-in mouse strain bearing the Lox M292R substitution was generated in the C57/B6 background using CRISPR/Cas9 genome-editing technology as previously described (3). following published procedures (39, 40) . Mice infused with saline were used as controls. After a week of AngII treatment, arterial pressure and heart rate were again continuously recorded using the telemeters, sampling every 5 min for 15 sec intervals for 3 days. Animals were fed a standard laboratory chow diet. After 28 days, animals were sacrificed under isoflurane anesthesia and vessels were collected for compliance studies and histological characterization.
Vessel compliance measurement
For vessel compliance measurements, the ascending aorta and left common carotid artery were excised and placed in a physiological saline solution. Vessels were then cleaned of surrounding fat and connective tissue and mounted onto a pressure arteriograph (Danish Myotechnology, Aarhus, Denmark). Experiments were done at 37°C in an organ bath containing physiological saline. The mounted vessels were visualized using a computerized imaging system, allowing continuous recording of vessel diameters. Vessel outer diameters were recorded while increasing intravascular pressure from 0 to 175 mmHg by increments of 25 mmHg (12 seconds per step). The average of three outer diameter measurements was taken at each pressure (40, 41) .
Protein quantification, hydroxyproline, and desmosine assays
Each ascending aorta was hydrolyzed at 105˚C overnight with 20 µL of 6 N hydrochloric acid (Thermo Fisher Scientific, Waltham, MA) and dried under vacuum in a SpeedVac. The dried pellet was dissolved in 400 µL of water and filtered with a 0.45-µm filter. Total protein, hydroxyproline, and desmosine levels were determined as described (42) .
Dihydorethidium staining for superoxide detection in aortic sections
Superoxide in aortic sections was detected using dihydroethidum (DHE) staining. In the presence of superoxide, DHE is oxidized to 2-hydroxyethidium, which is highly fluorescent and 
Immunofluorescence on aortic sections and area measurements
Ascending and descending aorta were dissected as above, placed in OCT compound, and the blocks were frozen on dry ice. Four-µm-thick cryosections were placed on glass slides and Carlsbad, CA) and imaged using the Zeiss Axioskope Fluorescence microscope equipped with the QImaging MicroPublisher 3.3 RTV camera using QCapture software as above. For area measurements, frozen sections from the descending aorta from 3-month-old mice were prepared as described above. The area between the internal elastic lamina and the external elastic lamina was traced in each 40x image using ImageJ software and measured in pixels 2 .
LOX activity assay
MEFs were grown in 10-cm dishes and maintained as above until fully confluent.
Twenty-four hours before collection, culture medium was replaced with DMEM lacking phenol red and FBS, supplemented with 50 µg/mL ascorbic acid and 0.1% BSA. Conditioned medium from each dish was concentrated using Amicon Ultra-15 Centrifugal Filter Units (Millipore, Burlington, MA) to a final volume of 1 mL. Cell lysates were collected by scraping in 1X PBS containing protease inhibitors. LOX activity in cell lysate and concentrated culture medium, incubated with and without the LOX inhibitor β-aminopropionitrile (BAPN), was quantified using the Amplex Red assay as previously described (3, 45) . Resorufin fluorescence, the product of Amplex Red oxidation, was measured at excitation and emission wavelengths (540 and 600 nm, respectively) every 30 min for 150 min using a Biotek H4 Hybrid Reader (Winooski, VT).
LOX activity was calculated as the difference between total activity and activity in the presence of BAPN. Differences in relative fluorescent units were tested using two-way ANOVA with Tukey's multiple comparisons test.
Immunofluorescence Imaging of primary cells
Primary MEFs were seeded in 4-chamber glass slides at 3x10 5 cells per/well. After three days in culture, the cells were fixed with cold methanol (two washes, five seconds each)
followed by three washes with blocking solution containing 1X PBS, 1% BSA, 1% fish gelatin 
Protein extraction from cell culture and aortic tissue
Cultured MEFs were switched to serum-free medium 24 hours before protein extraction.
MEFs in 10-cm dishes were incubated in 1 mL of lysis (RIPA) buffer (Sigma, St. Louis, MO) containing protease inhibitors for 30 min at 4°C. The lysates were scraped from the dish into microfuge tubes and centrifuged at 17,500 xg for 5 min and the supernatant was collected.
Conditioned medium from each dish was concentrated using Amicon Ultra- 
and Gapdh (Mm9999999915_g1), which was used as an internal control. Ten-µL reactions were performed in duplicate using a ViiA 7 Real-Time PCR System for Bip, Atf4 and Chop and QuantStudio 3
Real-Time PCR system (Applied Biosystems, Foster City, CA) for Agtr1a, Agtr1b, Agtr2, Mmp2, Mmp9, and Mmp12. All mRNA levels were normalized to Gapdh expression.
rBMP-1 Treatment
Protein was extracted from Lox 
Western blotting
Protein extracts from cells, concentrated condition medium, or tissues (generally 50 µg)
were analyzed using 10% Mini-PROTEAN TGX Stain-Free Protein Gels (Bio-RAD, Hercules, CA) run at 100 mV for one hour. The protein was then transferred to ProBlott Membrane 
Co-immunoprecipitation
Cell lysates were prepared from MEFs five days after confluency as described above. Immune complexes bound to the protein A beads were collected by centrifugation and washed with lysis buffer prior to boiling at 100°C for 10 min with Laemmli buffer containing DTT. The supernatant was collected by centrifugation and proteins were separated by SDS-PAGE and immunoblotted following the same protocol described above. 
Protein degradation analysis
Autophagy markers
Confluent MEFs in 6-well dishes were pretreated with 100 mM bafilomycin A1 (Sigma, St. Louis, MO) for 3 hours before cell lysates were collected. The protein samples were separated on 4-15% gradient gels for SDS-PAGE analysis. Immunoblotting was performed following the same procedure as above.
Lox-mApple plasmid cloning and expression
The mouse Lox cDNA in a mammalian expression vector driven by a pCMV promoter was purchased from GE Health 
Transmission electron microscopy
MEFs The samples were then incubated at RT for an additional hour, washed with cacodylate buffer, and treated with 1% OsO4/1.5% potassium ferrocyanide for 1 hour in the dark. After washing with ultrapure water, en bloc staining was performed in 2% uranyl acetate for 1 hour in the dark.
The samples were washed again in ultrapure water before dehydration in a graded acetone series.
Finally, the samples were embedded in Epon resin and cured in a 60°C oven for 48 hours. The processed samples were imaged using a Joel 1400 electron microscope.
Animal studies approval
All animal experiments were carried out following protocols approved by Washington University School of Medicine Institutional Animal Care and Use Committee.
Statistical analysis
One-way analysis of variance (ANOVA) with Tukey's multiple comparisons test was used to determine the significance, if any, between different groups, particularly genotypes.
When two variables were present, i.e. genotype and treatment or genotype and gene, two-way ANOVA with Tukey's multiple comparisons test was used to assess differences. If the same sample was measured repeatedly (i.e. at different pressures in the pressure-diameter curves in Figure 1C&D or at different timepoints in Figure 3 ), then repeated measures two-way ANOVA , and Lox -/-MEFs were immunoprecipitated with anticalnexin antibody, separated by SDS-PAGE, then immunoblotted with an anti-LOX antibody. Both wild-type and mutant LOX were immunoprecipitated with calnexin, but the level of calnexin-bound mutant LOX was much higher than wild-type LOX. Cell lysate from Lox -/-cells served as a negative control. , Lox +/Mu , and Lox Mu/Mu mice. One-way ANOVA with Tukey's multiple comparisons test was used to assess differences, which were minimal between the three genotypes. Data are presented as mean ± SD. ***P<0.001. 
